BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink.

Autor: Kansteiner, Fraiser
Zdroj: FiercePharma; 11/13/2024, pN.PAG-N.PAG, 1p
Databáze: Complementary Index
Externí odkaz: